Effectiveness of Modern Physical Agents in the Treatment of Pelvic Floor Dysfunctions
EMPHAT-PFD
The Effectiveness of Modern Physical Agents in Treating Pelvic Floor Dysfunctions, Improving Functional State, Life Quality, and Biosocial Functions During First-stage Pelvic Rehabilitation.
1 other identifier
interventional
250
1 country
1
Brief Summary
This clinical trial aims to determine whether adding modern physical agents (high-intensity laser therapy, magnetotherapy, radial shock wave therapy, kinesiotaping) in conjunction with classical rehabilitation interventions produces superior outcomes in treating pelvic floor dysfunction compared to classical rehabilitation interventions alone. It will also assess the safety of these agents in the context of pelvic floor dysfunction rehabilitation. The main questions it aims to answer are: Does adding modern physical agents to the treatment of pelvic floor dysfunction improve symptoms, impairments in functional state, quality of life, and biosocial functions more effectively than classical interventions alone? Participants who experience pelvic floor dysfunction during primary rehabilitation will receive: Either an individualized rehabilitation intervention plan comprising 20 classical procedures in combination with modern physical agents or classical interventions alone. Rehabilitation will take place in the outpatient rehabilitation department. Patients will visit the clinic for a comprehensive functional state assessment and then for individualized procedures; the entire plan will be delivered over three months, after which participants will return for follow-up checkups and assessments after the procedures and again after six months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2024
CompletedFirst Posted
Study publicly available on registry
January 29, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 9, 2029
January 29, 2025
January 1, 2025
3.5 years
October 26, 2024
January 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall change in bothering pelvic floor symptoms according to Global Rating of Change (GRC) scales
After rehabilitation, the overall change in bothering pelvic floor dysfunction symptoms according to Global Rating of Change (GRC) scales will be assessed. The Global Rating of Change (GRC) Scale is a tool used to assess a patient's perceived change in health status over time. The minimum value is 0, indicating "no change." The maximum value is 10, indicating "a very great deal better." Higher scores on the GRC Scale reflect a better outcome, showing greater perceived improvement in the patient's symptoms.
3 months
Secondary Outcomes (12)
Overall change in urinary dysfunction symptoms
3 months and 6 months
Overall change in fecal incontinence
3 months and 6 months
Overall change in pelvic pain
3 months and 6 months
Overall change in male sexual function
3 months and 6 months
Change in pelvic floor muscle contraction: ability to contract and relax pelvic floor muscles
3 months and 6 months
- +7 more secondary outcomes
Study Arms (2)
Intervention group
ACTIVE COMPARATORSubjects will receive classical rehabilitation interventions together with modern physical agents
Control
OTHERsubject will receive only classical rehabilitation interventions
Interventions
rehabilitation interventions containing modern physical agents together with classical interventions
Eligibility Criteria
You may qualify if:
- Patients older than 18 years old.
- One or more signs characteristic of pelvic floor dysfunctions are identified: elimination function disorders, pelvic organ prolapse, scar(s) (and lack of tissue mobility) in the perineum, pelvic floor muscle tone/strength disorders (hypoactivity/hyperactivity), neuromuscular control disorders, sexual dysfunctions, pain in the pelvis, perineum.
- Subjects capable of signing informed consent.
You may not qualify if:
- Oncological diseases or being actively investigated for oncological diseases.
- Any contraindications to methods of functional state examination or physical agents in the pelvic area that will be used in the study
- Individuals who refuse a detailed clinical examination of the perineum and pelvic floor muscles, functional testing, and/or functional ultrasound examination.
- Patients with urinary tract, prostate, genital, and other infections.
- Patients with inflammatory bowel diseases (ulcerative colitis, Crohn's disease, etc.).
- Persons for whom other health care professionals have already planned treatment of pelvic dysfunctions or other diseases during the expected participation period in the study that may interfere with participation in the study and/or significantly change the health status of the patient's pelvic floor.
- Pregnant or planning to become pregnant during the expected period of rehabilitation interventions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital of Lithuanian University of Health Sciences Kaunas Clinics
Kaunas, Kauno M. Sav., 50161, Lithuania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical medicine and rehabilitation physichian, Phd
Study Record Dates
First Submitted
October 26, 2024
First Posted
January 29, 2025
Study Start
March 1, 2025
Primary Completion (Estimated)
September 9, 2028
Study Completion (Estimated)
September 9, 2029
Last Updated
January 29, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
For now, we do not have enough human and financial resources to share IPD, but if our circumstances change, we are open to reconsidering this decision.